Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18397336rdf:typepubmed:Citationlld:pubmed
pubmed-article:18397336lifeskim:mentionsumls-concept:C0085494lld:lifeskim
pubmed-article:18397336lifeskim:mentionsumls-concept:C0038172lld:lifeskim
pubmed-article:18397336lifeskim:mentionsumls-concept:C0042313lld:lifeskim
pubmed-article:18397336lifeskim:mentionsumls-concept:C0145106lld:lifeskim
pubmed-article:18397336lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:18397336lifeskim:mentionsumls-concept:C0663241lld:lifeskim
pubmed-article:18397336lifeskim:mentionsumls-concept:C0036576lld:lifeskim
pubmed-article:18397336lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:18397336lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:18397336lifeskim:mentionsumls-concept:C0526513lld:lifeskim
pubmed-article:18397336pubmed:issue6lld:pubmed
pubmed-article:18397336pubmed:dateCreated2008-5-8lld:pubmed
pubmed-article:18397336pubmed:abstractTextThe ability of breakpoint and serum concentrations of teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin to select resistance was compared for isolates of methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant S. aureus (MRSA), Enterococcus faecalis and Enterococcus faecium. Mutation frequencies were always <10(-10), except for two isolates grown in the presence of teicoplanin at the trough serum concentration. After multistep selection, linezolid selected for resistance in staphylococci and enterococci, and serial exposure to certain concentrations of linezolid was more likely to select for stable resistance in MRSA, MSSA and enterococci than was exposure to glycopeptides and quinupristin-dalfopristin.lld:pubmed
pubmed-article:18397336pubmed:languageenglld:pubmed
pubmed-article:18397336pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18397336pubmed:citationSubsetIMlld:pubmed
pubmed-article:18397336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18397336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18397336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18397336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18397336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18397336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18397336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18397336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18397336pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18397336pubmed:statusMEDLINElld:pubmed
pubmed-article:18397336pubmed:monthJunlld:pubmed
pubmed-article:18397336pubmed:issn1469-0691lld:pubmed
pubmed-article:18397336pubmed:authorpubmed-author:DragoLLlld:pubmed
pubmed-article:18397336pubmed:authorpubmed-author:De VecchiEElld:pubmed
pubmed-article:18397336pubmed:authorpubmed-author:NicolaLLlld:pubmed
pubmed-article:18397336pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18397336pubmed:volume14lld:pubmed
pubmed-article:18397336pubmed:ownerNLMlld:pubmed
pubmed-article:18397336pubmed:authorsCompleteYlld:pubmed
pubmed-article:18397336pubmed:pagination608-11lld:pubmed
pubmed-article:18397336pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:meshHeadingpubmed-meshheading:18397336...lld:pubmed
pubmed-article:18397336pubmed:year2008lld:pubmed
pubmed-article:18397336pubmed:articleTitleA comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.lld:pubmed
pubmed-article:18397336pubmed:affiliationLaboratory of Clinical Microbiology, Department of Preclinical Science, LITA Vialba, University of Milan, Milan, Italy. lorenzo.drago@unimi.itlld:pubmed
pubmed-article:18397336pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18397336pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18397336pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18397336lld:pubmed